Research Site — Cary, North Carolina

Research Site is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 18 clinical trials with 3 currently active.

Therapeutic areas: Erectile Dysfunction, Gastroesophageal Reflux Disease (GERD), Migraine Disorders.

Sponsors: VIVUS LLC, AstraZeneca, Alder Biopharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cary

Browse all research sites in North Carolina · View every site in Cary

• Duke University Medical Center
• WakeMed Health & Hospitals
• Waverly Hematology Oncology
• Duke Cancer Center Cary
• GSK Investigational Site
• Pfizer Investigational Site
• PMG Research of Cary
• PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
• UNC Health Cancer Care Cary
• North Carolina Retina Associates
• Accellacare - Cary

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 18 clinical trials on record, with 3 currently active. Their work covers Erectile Dysfunction, Gastroesophageal Reflux Disease (GERD), Migraine Disorders.

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.